← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksAFJKRevenue History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

AFJK logoAimei Health Technology Co., Ltd (AFJK) Revenue History

Annual and quarterly revenue from 2023 to 2025

TTM Revenue
$0
0
YoY Growth
-
Latest Quarter
$0
Q4 2025
QoQ Growth
-

Compound Annual Growth Rate (CAGR)

3-Year-
5-Year-
10-Year-
Highest Annual Revenue$0 (0)
Highest Quarter$0 ()

Loading revenue history...

AFJK Revenue Growth

1-Year Growth
-
3-Year CAGR
-
5-Year CAGR
-
10-Year CAGR
-
TTM vs Prior Year-
Peak Annual Revenue$0 (0)

Download Historical Data

3 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

AFJK Revenue Analysis (2023–2025)

As of May 8, 2026, Aimei Health Technology Co., Ltd (AFJK) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.

Looking at the longer-term picture, AFJK's historical revenue data shows various trends over time.

When compared to Financial Services sector peers including CANG (+1197.2% YoY), BTBT, and CLOV (+48.7% YoY). Compare AFJK vs CANG →

AFJK Revenue vs Peers

Revenue metrics vs comparable public companies

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
AFJK logoAFJKCurrent$0---
CANG logoCANG$804M+1197.2%-11.0%22.2%
BTBT logoBTBT$164M--16.8%
CLOV logoCLOV$1.9B+48.7%+23.4%-4.4%
ACMR logoACMR$901M+15.2%+41.9%12.1%
GDRX logoGDRX$797M-1.2%+7.7%13.4%
Best in groupLowest in group

AFJK Historical Revenue Data (2023–2025)

Showing 3 of 3 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2025$0-$0-$-835,759-
2024$0-$0-$-1,065,000-
2023$0-$0-$-28,459-

See AFJK's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is AFJK Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare AFJK vs BRK-A

Side-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..

Start Comparison

AFJK — Frequently Asked Questions

Quick answers to the most common questions about buying AFJK stock.

Is AFJK's revenue growth accelerating or slowing?

AFJK TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.

What is AFJK's long-term revenue growth rate?

Aimei Health Technology Co., Ltd's 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.

How is AFJK's revenue distributed by segment?

AFJK reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2023-2025 are available for download. Segment mix reveals concentration and diversification trends.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

AFJK Revenue Over Time (2023–2025)